When patients with bowel problems ask about cannabis, gastroenterologists need to be prepared with the straight dope. “We get questions from … patients all the time” about medical marijuana, said Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease [IBD] at Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, both in Boston.

A 2014 study found that between 16% and 50% of IBD patients report using cannabis to control their symptoms, and the majority claim the drug is “very helpful” (Inflamm Bowel Dis 2014;20:472-480), Dr. Cheifetz said. Moreover, roughly half of patients with Crohn’s disease who have not used cannabis expressed interest in doing so if the substance were legal.

A request for a cannabis prescription might leave physicians wondering what they can and cannot do, since cannabis is considered a Schedule I drug federally but is permitted for medical use in 25 states and the District of Columbia, according to Governing magazine.

Click to read the full article on Gastroenterology & Endoscopy News.

Leave a Reply

Your email address will not be published. Required fields are marked *

About Canna Magazine

This is the "wpengine" admin user that our staff uses to gain access to your admin area to provide support and troubleshooting. It can only be accessed by a button in our secure log that auto generates a password and dumps that password after the staff member has logged in. We have taken extreme measures to ensure that our own user is not going to be misused to harm any of our clients sites.